乳腺癌靶向治疗相关心血管毒性的研究进展

Advances in Cardiovascular Toxicity Associated with Targeted Therapy for Breast Cancer

乳腺癌是女性常见的恶性肿瘤之一。由于近年来乳腺癌诊疗手段的丰富和靶向治疗药物的广泛应用,乳腺癌患者的生存期较前有所延长,死亡率呈现下降的趋势。然而,与靶向药物治疗相关的心血管毒性在乳腺癌患者治疗过程中的发生率也随之升高,本文就乳腺癌靶向药物治疗相关心血管毒性的研究进展作一综述。

Breast cancer is one of the most common malignant tumors in women.Because of the abundance of diagnosis and treatment methods and the wide application of targeted therapy drugs in recent years,the survival time of breast cancer patients is longer than before and the mortality rate shows a downward trend.However,the incidence of cardiovascular toxicity associated with targeted drug therapy in breast cancer patients is also increasing.This article reviews the research progress of cardiovascular toxicity associated with targeted drug therapy in breast cancer.